logo

Quick Facts

Share SHARE

Nordex AG (NRDXF.PK) announced Erdem Holding A.S. has placed another order with the company to deliver and install a wind farm. The manufacturer is to supply ten N131/3900 turbines for the Eber wind farm. A Premium Service covering at least 15 years also forms part of the deal. The Eber project...

Fidelity National Information Services (FIS) announced it has commenced tender offers to purchase for cash up to $2 billion aggregate principal amount of its securities. The Tender Offers will expire on July 24, 2017. FIS also announced it intends to make an offering of senior notes denominated in...

Hikma Pharmaceuticals plc (HIK, HIK.L) announced the planned retirement of Michael Raya, CEO of the US business, effective at the end of the current year. The Group also announced organisational changes to the US business. From 1 July 2017, the US business will be organized into two entities:...

BHP (BHP.AX, BLT.L, BBL, BHP) announced approval of US$184 million in initial funding for the South Flank sustaining mine project in the central Pilbara, Western Australia. BHP President Operations, Minerals Australia, Mike Henry, said the funding would generate several hundred construction jobs and...

Genentech, a member of the Roche Group (RHHBY), reported positive data from the primary analysis of the Phase III HAVEN 1 study in adults and adolescents and interim analysis of the Phase III HAVEN 2 study in children evaluating once-weekly subcutaneous emicizumab prophylaxis (preventative) for the treatment...

Agios Pharmaceuticals, Inc. (AGIO) reported updated data from its pyruvate kinase-R (PKR) activator demonstrating the potential for the first disease-modifying treatment for patients with pyruvate kinase deficiency. DRIVE PK is an ongoing global open-label, Phase 2, safety and efficacy trial evaluating...

Verastem, Inc. (VSTM) reported long-term follow-up data from the DYNAMO study, which met its primary endpoint of Overall Response Rate at the final analysis. DYNAMO is a Phase 2 clinical study evaluating duvelisib, the company's investigational oral monotherapy, dual inhibitor of phosphoinositide-3-kinase...

Novo Nordisk (NVO) announced the headline results from a 52-week double-blind phase 2 clinical trial with once-daily subcutaneous semaglutide investigating safety and potential for inducing and maintaining weight loss in people with obesity. In the trial, 957 people with obesity were randomised to...

Forestar Group Inc. (FOR) announced that it received a revised binding proposal from D.R. Horton Inc. (DHI) to acquire 75% of the outstanding shares of Forestar common stock for $17.75 per share in cash (an increase from D.R. Horton's previous offer of $16.25 in cash per share to acquire 75% of the outstanding...

Alexion Pharmaceuticals Inc. (ALXN) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion to extend the current therapeutic indication for Soliris (eculizumab) to include the treatment of refractory generalized myasthenia gravis...

Biogen (BIIB) said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA has issued a positive opinion for IMRALDI (also known as SB5), an adalimumab biosimilar candidate referencing Humira. The positive opinion will now be referred to the European...

RWE AG (RWEOY.PK) announced the company's Executive Board intends to propose to the annual general meeting in 2018 a one-off special dividend amounting to 1.00 euros per common and preferred share. The special dividend payment shall be made as a one-off payment in addition to the 0.50 euros dividend...

ParkerVision Inc. (PRKR) said that the Regional Court of Munich is holding its decision in the ParkerVision v. Apple case until after the German Federal Patent Court rules on the related pending nullity (validity) action. The Company's final resolution in its German case against LG is also pending...

BlackBerry Limited (BBRY, BB.TO) announced it has received acceptance from the Toronto Stock Exchange with respect to a normal course issuer bid to purchase for cancellation up to 31 million BlackBerry common shares, representing approximately 6.4% of the outstanding public float as at May 31, 2017....

Finish Line Inc. (FINL) said that it still expects comparable store sales to increase in the low-single digits range and adjusted earnings per share to be between $1.12 and $1.23 for the 53 week fiscal year ending March 3, 2018. Analysts polled by Thomson Reuters expect the company to report earnings...

Follow RTT